on 21 Oct 2018
Last Applicant/ Owned by
82152 Martinsried
DE
Serial Number
79067099 filed on 21st Oct 2008
Registration Number
4434280 registered on 19th Nov 2013
Correspondent Address
JEFFREY A SMITH
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Scaffold-free or solid phase free pharmaceutical and veterinary preparations used in tissue and cell-based spheroid cultures for the diagnosis and treatment of cancer; collection of biological tissue and cells, namely, surgical tissues and cells intended for the generation of cell clusters and cell aggregates for medical purposes; tissue, namely, surgical tissues, for diagnosis and treatment of caRead More
Scaffold-free and solid phase free chemical and chemical preparations used in tissue and cell-based spheroid cultures for scientific purposes; chemical preparations, namely, collections of biological tissues and cells for scientific purposes; tissue in the nature of biological tissue, namely, blood, stem cells, tumour cells, fibroblasts, foam cells, glial cells, adipocytes, benign and malignant primary cells, hybridomas, antibody producing cells; arrays of biological cells, namely, cancer cells, benign cells, stem cells, tumour cells, fibroblasts, foam cells, glial cells, adipocytes, benign and malignant primary cells, hybridomas, antibody producing cells; fixed arrays of biological cells, namely, cancer cells, benign cells, stem cells, tumour cells, fibroblasts, foam cells, glial cells, adipocytes, benign and malignant primary cells, hybridomas, antibody producing cells; biological cells prepared into a format for scientific purposes and research for scientific research use; cell culture systems, three-dimensional cell culture system comprising cell clusters and aggregates for scientific research use
Scaffold-free or solid phase free pharmaceutical and veterinary preparations used in tissue and cell-based spheroid cultures for the diagnosis and treatment of cancer; collection of biological tissue and cells, namely, surgical tissues and cells intended for the generation of cell clusters and cell aggregates for medical purposes; tissue, namely, surgical tissues, for diagnosis and treatment of cancer and for medical purposes; fibroblasts, foam cells, glial cells, stem cells, adipocytes, benign and malignant primary cells, hybridomas, antibody producing cells for the generation of cell clusters or cell aggregates
Compilation and management of computerized databases used for tissue and cell-based spheroid cultures
Scientific and technological services and research and design in the field of integrated system architecture that allows for the rapid development of highly interactive and customizable learning applications; computer diagnostic services; diagnostic testing of humans for medical research purposes; medical research services; medical research in the field of oncology; medical research in the field of disease indications and identification of tumor indications; testing of drugs, biological and chemical preparations for medical research purposes; pharmaceutical research, inspection and development; pharmaceutical drug development services; medical and scientific research, namely, conducting clinical trials concerning biological and chemical preparations and pharmaceuticals; medical and scientific research, namely, researching profiles of biological and chemical preparations, pharmaceuticals, antigens; testing for scientific and medical research purposes of combinations of biological and chemical preparations and pharmaceuticals; testing for medical research purposes to determine the chemo-resistance and chemo-sensitivity of biological and chemical preparations and pharmaceuticals; medical research in the nature of testing the efficacy and toxicity of biological and chemical preparations and pharmaceuticals; medical research in the nature of testing the effects of biological and chemical preparations and pharmaceuticals on cell toxicity levels; medical research in the nature of pharmacokinetic testing of biological and chemical substances and known pharmaceuticals; medical research concerning the absorption, delivery, metabolism, excretion and toxicity testing of biological and chemical preparations and pharmaceuticals ; medical and scientific research in the field of pharmaceuticals, genetic changes induced by biological or chemical preparations or pharmaceuticals, and pharmaceutical dosing levels; research and development of pharmaceutical treatment therapies for others; scientific research concerning tumour biology, progression and metastasis; medical research concerning optimal treatment and therapy regimes for individuals; medical research concerning optimal cancer therapy for individuals; research and development of new products for others in relation to prediction of cancer therapy; scientific and medical research in the field of radiotherapy; research, development and design of new radiotherapy products for others; scientific and medical research in the field of radiochemotherapy; research, development and design of new products for others in the field of radiochemotherapy; scientific and medical research in the field of stem cells and biomarker discovery, characterization and development; medical research in the fields of ex-vivo therapies, patient material profiling, tumor profiling, in vitro modeling of tissue and biological systems, cell culture systems, three-dimensional cell culture systems, and three-dimensional culture of donor and patient cells; laboratory research services, namely, isolation, culture and treatment of donor and patient tissues and cells for medical research purposes; research laboratory services, namely, preparation of cell lines, primary tissues and fluids, and biological material into a format for scientific and medical research purposes; medical research concerning immunohistology, immunohistology preparation and investigation;Opposition No. 912064346research laboratory services, namely, creation and preparation of biological material into or onto a format for immunohistology investigation, creation and preparation of biological material on a solid or wax support, preparation of sections or slices of biological material on to slides, all for medical research purposes; medical research concerning small molecule development, preparation and generation, antibody research, development, preparation and generation, and vaccine research, development, preparation and generation; provision of information and data relating to scientific and technological research and development; provision of information and data relating to medical and veterinary research and development; provision of information and data relating to scientific and medical research concerning pharmaceuticals, drug testing, drug discovery and development, and testing of biological material; all of the aforementioned services relating to or using tissue and cell-based spheroids cultures
Medical and veterinary services; medical diagnostic testing services; medical diagnostic testing services of humans; medical diagnostic and clinical testing services; medical and clinical oncology diagnostic testing services for humans; medical diagnostic testing services in the field of oncology; performing diagnosis of disease indications, performing diagnosis of tumour disease indications; medical screening services for drugs, biological and chemical entities and potential and known pharmaceuticals; medical services, namely, medical testing for and identifying antigens and providing drug therapy for inhibiting antigens; providing individualizing cancer therapy services; providing medical diagnostic services for cancer therapy; medical services, namely, personalized cancer therapy; medical services, namely, radiotherapy; medical services, namely, radiochemotherapy; medical services, namely, preparations of ex-vivo therapies; all relating to medical and veterinary fields; all of the aforementioned services relating to or using tissue and cell-based spheroids cultures
No 79067099
No Service Mark
No
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 24th May 2019 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED |
| 24th May 2019 | DEATH OF INTERNATIONAL REGISTRATION |
| 19th Nov 2018 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| 06th Mar 2014 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 19th Feb 2014 | FINAL DISPOSITION PROCESSED |
| 19th Feb 2014 | FINAL DISPOSITION NOTICE SENT TO IB |
| 19th Feb 2014 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 19th Nov 2013 | REGISTERED-PRINCIPAL REGISTER |
| 16th Oct 2013 | OPPOSITION DISMISSED NO. 999999 |
| 16th Oct 2013 | TTAB RELEASE CASE TO TRADEMARKS |
